Approvals/TGA/BEVESPI AEROSPHERE 7.2/5 glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pressurised metered dose inhaler

Approved

STANDARD

BEVESPI AEROSPHERE 7.2/5 glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pressurised metered dose inhaler

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: Dec 9, 2025
Approval ID: 671083db7c7b2047
Company: AstraZeneca Pty Ltd
Type: Standard

Approval Details

Approval Id: 671083db7c7b2047
Product Name: BEVESPI AEROSPHERE 7.2/5 glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pressurised metered dose inhaler
Artg Id: 291060
Artg Name: BEVESPI AEROSPHERE 7.2/5 glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pressurised metered dose inhaler
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2018-10-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

671083db7c7b2047

Type

Standard

Back to TGA Approvals